Vinay Shah
2023 - Virpax Pharmaceuticals
In 2023, Vinay Shah earned a total compensation of $324K as Chief Financial Officer at Virpax Pharmaceuticals.
Compensation breakdown
| Bonus | $115,000 |
|---|---|
| Option Awards | $86,000 |
| Salary | $123,000 |
| Total | $324,000 |
Shah received $123K in salary, accounting for 38% of the total pay in 2023.
Shah also received $115K in bonus and $86K in option awards.
Rankings
In 2023, Vinay Shah's compensation ranked 2,470th out of 3,006 executives tracked by ExecPay. In other words, Shah earned more than 17.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,470 out of 3,006 | 18th |
Division Manufacturing | 1,383 out of 1,650 | 16th |
Major group Chemicals And Allied Products | 807 out of 918 | 12th |
Industry group Drugs | 787 out of 881 | 11th |
Industry Pharmaceutical Preparations | 565 out of 637 | 11th |
Source: SEC filing on December 9, 2024.
Shah's colleagues
We found four more compensation records of executives who worked with Vinay Shah at Virpax Pharmaceuticals in 2023.
News
Virpax Pharmaceuticals CEO Anthony Mack's 2023 pay jumps 55% to $1.2M
June 12, 2024
Versartis CEO Gail McIntyre's 2022 pay rises 4% to $1.6M
September 5, 2023
Versartis CEO Gail McIntyre's 2021 pay rises 8% to $1.5M
August 4, 2022
Versartis CEO Rekha Hemrajani's 2020 pay slips 17% to $3M
July 23, 2021
Versartis CEO Jay Shepard's 2019 pay jumps 61% to $1.3M
August 4, 2020
Versartis CEO Jay Shepard's 2018 pay falls 80% to $818K
August 9, 2019